European Journal of Molecular & Clinical Medicine

Abstract

Chronic Obstructive Pulmonary Disease is a progressive irreversible inflammatory disease that affects the lungs and reduces the airflow. It is a preventable and treatable disease in the worldwide population By the year 2030, COPD will be in top 5th diseases affecting the worldwide population and in top 3, according to mortality rate. [1, 2, 3] Approximately, 30 million people are suffering from COPD in India. According to Global Initiative Chronic Obstructive Lung Disease (GOLD) guidelines, a general definition of COPD is “Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant extra pulmonary effects that may be contributed the severity in individual patient”. The pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response in lung to noxious particles and gases. [4,